166 related articles for article (PubMed ID: 24165038)
1. Five-year actual survival after pancreatoduodenectomy for pancreatic head cancer.
Perysinakis I; Avlonitis S; Georgiadou D; Tsipras H; Margaris I
ANZ J Surg; 2015 Mar; 85(3):183-6. PubMed ID: 24165038
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M
Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197
[TBL] [Abstract][Full Text] [Related]
5. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
6. Results of a pylorus-preserving pancreatoduodenectomy for pancreatic cancer: a comparison with results of the Whipple procedure.
Takada T; Yasuda H; Amano H; Yoshida M; Ando H
Hepatogastroenterology; 1997; 44(18):1536-40. PubMed ID: 9427018
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
Kuhlmann KF; de Castro SM; Wesseling JG; ten Kate FJ; Offerhaus GJ; Busch OR; van Gulik TM; Obertop H; Gouma DJ
Eur J Cancer; 2004 Mar; 40(4):549-58. PubMed ID: 14962722
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
[TBL] [Abstract][Full Text] [Related]
10. [Results of resection for ductal adenocarcinoma of the pancreatic head].
Morin B; Chiche L; Salame E; Lebreton G; Rouleau V; Segol P
Ann Chir; 2006 Nov; 131(9):518-23. PubMed ID: 17045233
[TBL] [Abstract][Full Text] [Related]
11. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
12. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
13. Increasing body mass index portends abbreviated survival following pancreatoduodenectomy for pancreatic adenocarcinoma.
Mathur A; Luberice K; Paul H; Franka C; Rosemurgy A
Am J Surg; 2015 Jun; 209(6):969-73. PubMed ID: 25916614
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
15. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990
[TBL] [Abstract][Full Text] [Related]
16. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.
Kato K; Yamada S; Sugimoto H; Kanazumi N; Nomoto S; Takeda S; Kodera Y; Morita S; Nakao A
Pancreas; 2009 Aug; 38(6):605-12. PubMed ID: 19629002
[TBL] [Abstract][Full Text] [Related]
19. Results of pancreatic resection associated with portal vein resection in an Australian tertiary care centre.
Iorgulescu DG; Ling S; Nikfarjam M; Fink MA; Jones R; Muralidharan V; Starkey G; Christophi C
ANZ J Surg; 2015 Apr; 85(4):270-3. PubMed ID: 24712309
[TBL] [Abstract][Full Text] [Related]
20. Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study.
Renz BW; Khalil PN; Mikhailov M; Graf S; Schiergens TS; Niess H; Boeck S; Heinemann V; Hartwig W; Werner J; Bruns CJ; Kleespies A
Int J Surg; 2016 Apr; 28():118-25. PubMed ID: 26906329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
